Saturday, September 23, 2023
Saturday, September 23, 2023 Receives FDA Clearance and Breakthrough Device Designation, a leader in AI-powered medical imaging solutions, announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the triage and notification of obstructive hydrocephalus (OHCP) on non-contrast brain CT scans. has also received FDA Breakthrough Device Designation for its obstructive hydrocephalus software tool. This is the first radiology triage device to be granted Breakthrough status since the inception of the FDA Breakthrough Devices Program*.

The FDA’s Breakthrough Devices Program identifies medical devices that improve the treatment or diagnosis of life-threatening or debilitating conditions. It aims to grant quick access to these devices to healthcare providers. To be authorized for marketing, these devices must meet the FDA’s strict safety and effectiveness standards.’s cutting-edge solution enables both passive and active notifications for suspected OHCP cases identified on unenhanced head CT scans. The newly cleared algorithm bolsters’s U.S. portfolio to a total of ten FDA-cleared findings – five for chest X-rays (CXR) and five for head CT scans (CTB), positioning as a provider of one of the U.S.’s most comprehensive FDA-cleared AI triage solutions.

Lakshmi Gudapakkam, CEO of, stated: “Our FDA clearances, including this latest addition, underscore our dedication to revolutionizing medical imaging. is proud to offer a comprehensive suite of AI solutions that significantly enhance diagnostic capabilities and assist in delivering prompt, life-saving interventions for conditions like obstructive hydrocephalus.”

Dr Rick Abramson, Chief Medical Officer at, added: “Our advanced algorithms support radiologists by facilitating prioritization of non-contrast head CT studies with suspected critical findings, thereby optimizing radiology workflow. With its set of clearances, promotes faster report turnaround times by identifying and elevating critical cases for immediate attention.”

Obstructive hydrocephalus, a potentially life-threatening condition, involves the accumulation of cerebrospinal fluid in the cranial vault, leading to elevated intracranial pressure that can escalate rapidly if left untreated. The Breakthrough Device Designation from the FDA highlights’s commitment to expediting patient access to advanced medical solutions that address critical healthcare needs.

For more information about and its groundbreaking AI solutions, please visit here.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Lipogems® Announces 140 Independent Peer Reviewed Publications with 5 Years of Follow up in Orthopaedics

Giorgio Ninzoli, President of Lipogems International. "The gold standard for evidence is 1 year follow up and we are excited to report 5 years follow up with positive results after a single injection of MicroFat."

Stryker’s Triathlon Tritanium Baseplate Marks a Decade of Positive Patient Impact

Marking its 10th anniversary, the Triathlon Tritanium baseplate is designed with Stryker Orthopaedic Modeling and Analytics (SOMA) and enabled by Stryker's proprietary additive manufacturing technology.

Medtronic Diabetes Announces CE Mark for New Simplera™ CGM with Disposable All-in-one Design

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience

Study Outcomes Could Provide Insights Into New Targeted Treatments to Manage this Challenging Disease

The study aims to determine if immediate biological preservation of patient-derived chordoma tumor tissue, collected intraoperatively and implanted for serial sampling in translational research, will provide new insights into the biological weakness of the disease and contribute to developing improved treatment therapies reports NICO.

Henkel Joins with MedTech Europe to Drive Innovation In the Medical Technology Industry

Henkel has a long history of supporting the medical technology industry with its advanced adhesive and surface solutions. Through this, Henkel and MedTech Europe will collaborate on various initiatives such as supporting research and development projects, driving thought leadership and engaging in industry forums.

By using this website you agree to accept Medical Device News Magazine Privacy Policy